إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 150 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - cysteamine as bitartrate - hard capsule - cysteamine as bitartrate 50 mg - mercaptamine - cystagon is indicated for the treatment of proven nephropathic cystinosis.cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - betaine anhydrous - powder for solution - betaine anhydrous 1 g/g - betaine - treatment of homocystinuria.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - telotristat ethyl as etiprate - film coated tablets - telotristat ethyl as etiprate 250 mg - xermelo is indicated for the treatment of carcinoid syndrome diarrhoea in combination with somatostatin analogue (ssa) therapy in adults inadequately controlled by ssa therapy.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - carglumic acid - tablets dispersible - carglumic acid 200 mg - carglumic acid - carbaglu is indicated in treatment of :- hyperammonaemia due to n - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.

إسرائيل - الإنجليزية - Ministry of Health

medison pharma ltd - carglumic acid - tablets dispersible - carglumic acid 200 mg - carglumic acid - carbaglu is indicated in treatment of :- hyperammonaemia due to n - acetylglutamate synthase primary deficiency.- hyperammonaemia due to isovaleric acidaemia.- hyperammonaemia due to methymalonic acidaemia.- hyperammonaemia due to propionic acidaemia.